TrialFind
Search
About
Saved trials
Back to results
Completed
Phase 2
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients
NCT00642928
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Pitié-Salpêtrière Hospital
Paris, France
View on ClinicalTrials.gov
Official details
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients — TrialFind